Skyhawk Teams With Sanofi on Oncology and Immunology Targets in Deal Worth Potentially $2 Billion

Skyhawk Therapeutics, a three-year-old biotech spawned by entrepreneur, inventor and documentary filmmaker Bill Haney, has inked a new deal with Sanofi that has the two companies working together on challenging oncology and immunology targets.
Source: Drug Industry Daily